| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA3252706 | F | Immunosuppressive activity against PHA-stimulated proliferation in rat T-lymphocytes assessed as cell viability at 1 uM after 6 days by [3H]thymidine incorporation method relative to control | Rattus norvegicus | 7 | ALA3244180 | cell-based format | Scientific Literature | |
| 2. | ALA3252707 | F | Immunosuppressive activity against PHA-stimulated proliferation in rat T-lymphocytes assessed as cell viability at 100 uM after 6 days by [3H]thymidine incorporation method relative to control | Rattus norvegicus | 6 | ALA3244180 | cell-based format | Scientific Literature | |
| 3. | ALA3252708 | F | Immunosuppressive activity against PHA-stimulated proliferation in rat T-lymphocytes assessed as cell viability at 0.01 to 0.1 uM after 6 days by [3H]thymidine incorporation method relative to control | Rattus norvegicus | 6 | ALA3244180 | cell-based format | Scientific Literature | |
| 4. | ALA3252709 | F | Growth inhibition of human MGL8 cells at 5 uM after 48 hrs | Homo sapiens | 6 | ALA3244180 | cell-based format | Scientific Literature | |
| 5. | ALA3252710 | F | Growth inhibition of human MGL8 cells at 50 uM after 48 hrs relative to control | Homo sapiens | 6 | ALA3244180 | cell-based format | Scientific Literature | |
| 6. | ALA3252711 | F | Growth inhibition of human MGL8 cells at 500 uM after 48 hrs relative to control | Homo sapiens | 6 | ALA3244180 | cell-based format | Scientific Literature | |
| 7. | ALA3252712 | F | Antiviral activity against HSV2 infected in BHK cells assessed as reduction of viral plaque at 4 uM after 24 hrs | Human alphaherpesvirus 2 | 5 | ALA3244180 | organism-based format | Scientific Literature | |
| 8. | ALA3252713 | F | Antibacterial activity against Staphylococcus aureus at 1 mg/ml | Staphylococcus aureus | 4 | ALA3244180 | organism-based format | Scientific Literature | |
| 9. | ALA3252714 | F | Antibacterial activity against Bacillus subtilis at 1 mg/ml | Bacillus subtilis | 4 | ALA3244180 | organism-based format | Scientific Literature | |
| 10. | ALA3252715 | F | Antibacterial activity against Sarcina lutea at 1 mg/ml | Micrococcus luteus | 4 | ALA3244180 | organism-based format | Scientific Literature | |
| 11. | ALA3252716 | F | Antibacterial activity against Proteus vulgaris at 1 mg/ml | Proteus vulgaris | 4 | ALA3244180 | organism-based format | Scientific Literature | |
| 12. | ALA3252717 | F | Antibacterial activity against Salmonella gallinarum at 1 mg/ml | Salmonella enterica subsp. enterica serovar Gallinarum | 4 | ALA3244180 | organism-based format | Scientific Literature | |
| 13. | ALA3252718 | F | Antibacterial activity against Escherichia coli at 1 mg/ml | Escherichia coli | 4 | ALA3244180 | organism-based format | Scientific Literature | |
| 14. | ALA3252719 | F | Antibacterial activity against Pseudomonas aeruginosa at 1 mg/ml | Pseudomonas aeruginosa | 4 | ALA3244180 | organism-based format | Scientific Literature | |
| 15. | ALA3252720 | F | Antibacterial activity against Pseudomonas solanacearum at 1 mg/ml | Ralstonia solanacearum | 4 | ALA3244180 | organism-based format | Scientific Literature | |
| 16. | ALA3252721 | F | Antibacterial activity against Serratia marcescens at 1 mg/ml | Serratia marcescens | 4 | ALA3244180 | organism-based format | Scientific Literature | |
| 17. | ALA3252722 | F | Antifungal activity against Saccharomyces pastorianus at 1 mg/ml | Saccharomyces pastorianus | 4 | ALA3244180 | organism-based format | Scientific Literature | |
| 18. | ALA3252723 | F | Antifungal activity against Neurospora crassa at 1 mg/ml | Neurospora crassa | 4 | ALA3244180 | organism-based format | Scientific Literature | |
| 19. | ALA3252724 | F | Antifungal activity against Candida albicans at 1 mg/ml | Candida albicans | 4 | ALA3244180 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!